This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 - 25 November 2023 and includes updates on updates SARS-CoV-2 variant classifications, the increase of pediatric respiratory infections in China, Avian influenza in fur farms, West Nile virus, cholera, and an overview of respiratory virus epidemiology.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 October - 4 November 2023 and includes updates on West Nile virus, the mass gatherings at the Rugby World Cup 2023 and the detection of Crimean-Congo haemorrhagic fever virus in ticks in southern France.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 September 2023 and includes updates on severe floods, Severe floods, Avian influenza, human cases with swine influenza, COVID-19, West Nile Virus, Cholera and mass gathering monitoring for the Rugby World Cup 2023.
Tuberculosis (TB) is a major cause of morbidity and mortality in Europe. High-quality laboratory diagnosis of TB is the basis for both individual patient treatment and surveillance.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 August - 2 September and includes updates on Legionnaires’ disease, dengue cases, avian influenza, West Nile virus, COVID-19 and cholera.
For 2021, the 30 countries in the European Union/European Economic Area (EU/EEA) reported a total of 33 527 tuberculosis (TB) cases (7.4 per 100 000 population).
Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis B. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis B.